Clinical Trials Insight: 700043711

Trial Profile

Clinical Trials Insight: 700043711

Phase of Trial: Phase II

Latest Information Update: 23 Apr 2009

At a glance

  • Drugs Radequinil (Primary)
  • Indications Dementia
  • Focus Therapeutic Use
  • Sponsors Sumitomo Dainippon Pharma
  • Most Recent Events

    • 23 Apr 2009 New trial record.
    • 17 Apr 2009 Based on results of a phase II trial in the US (see trial profile 700031303), Dainippon Sumitomo Pharma has discontinued development of this compound both in Europe and abroad, according to a Dainippon Sumitomo Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top